Luciana Griebel advises clients on strategic transactions, including cross-border mergers and acquisitions (M&A), joint ventures, and minority investments. Bringing a keen understanding of global acquisitions and divestitures, Luciana partners with life sciences transactions (LST) lawyers to help global pharmaceutical, biotechnology, and medical device companies achieve their growth objectives. Luciana also regularly represents leading technology companies in significant transactions and assists clients with compliance and corporate governance matters.
Luciana brings an in-house perspective from time spent in the legal department of a global pharmaceutical company and with a mobile-first games powerhouse. Fluent in many languages, Luciana speaks English, French, German, Italian, Romanian, and Spanish.
Beyond her private practice, Luciana does pro bono work for charities in which she advises on a range of corporate matters, including one focused on the development of renewable energy technologies in Africa and South America as well as a leading UK children’s charity.
She is an active member of the American Bar Association (ABA), currently serving as vice-chair of its International M&A Subcommittee and editor of Deal Points, the publication of the ABA’s M&A Committee.
Recommended, M&A: Lower Mid-Market Deals, £100M-£750M in London, The Legal 500 UK (2024)
Recommended, M&A: Upper Mid-Market and Premium Deals, £500M+ in London, The Legal 500 UK (2023)
Member, American Bar Association
Vice-chair, American Bar Association International M&A Subcommittee